10-41

Thank You for the article.

An extensive and comprehensive study - way beyond my scientific understanding - both Enzalutamide and Apabetalone are  cited in the study. Reference 33 in the study refers to Betonmace and the planned Covid-19 trial is mentioned. This should certainly spotlight BET Inhibition as a therapy for the virus. I was unaware until reading this piece that males are more at risk for serious Covid complications. This study highlights BET Inhibition and should propel RVX-208 and ZEN-3694 from obscurity to the mainstream.

Chicagoest